Overview
David Shames practices in Shanghai, China. Mr. Shames is rated as a Distinguished expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
His clinical research consists of co-authoring 79 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Shames isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Shames isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Mr. Shames isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Anal CancerMr. Shames isExperienced. Learn about Anal Cancer.
- EGFR Positive Lung CancerMr. Shames isExperienced. Learn about EGFR Positive Lung Cancer.
- Gastroesophageal Junction CancerMr. Shames isExperienced. Learn about Gastroesophageal Junction Cancer.
- Ovarian CancerMr. Shames isExperienced. Learn about Ovarian Cancer.
- Urothelial CancerMr. Shames isExperienced. Learn about Urothelial Cancer.